Recurrent Omental Hemangiopericytoma: A Therapeutic Challenge
Recommended Citation
Jaber S, Winer I, and Rasool N. Recurrent omental hemangiopericytoma: A therapeutic challenge. Case Rep Obstet Gynecol 2016; 2016:2075157.
Document Type
Article
Publication Date
1-1-2016
Publication Title
Case Rep Obstet Gynecol
Abstract
Hemangiopericytomas are vascular tumors with a susceptibility to arise anywhere in the human body. We present a case of a 68-year-old female with primary omental hemangiopericytoma and a two-time recurrence managed with surgery and close follow-up. The first recurrence was at 52 months and the second at 37 months following the prior presentation. No adjuvant chemotherapy or radiation therapy was administered. Given the widespread nature of the cell of origin, routine follow-up postoperatively with interval imaging in order to detect recurrences is imperative. Pathologic tumor characteristics may determine potential for recurrence and may also assist in determining whether adjuvant treatment modalities should be included in the management plan. Review of the English literature reveals a total of 24 cases of omental hemangiopericytomas inclusive of the current report.
PubMed ID
27088021
Volume
2016
First Page
2075157
